TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Merck: FDA reviewing tablet to eliminate allergy

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

By The Associated Press
Thursday, March 28, 2013, 12:01 a.m.
 

Drugmaker Merck & Co. says federal regulators are reviewing its application to sell a new type of treatment for grass pollen allergy that reduces symptoms over time, rather than just temporarily relieving the sneezing and itching.

The treatment, a tablet that dissolves under the tongue, could become the first alternative available in the United States to a long series of uncomfortable allergy shots. Both methods work by gradually desensitizing the patient's immune system to the substance triggering the allergic reaction. Merck's immunotherapy, still unnamed, would be taken daily throughout allergy season.

for three years.

The company, which is based in Whitehouse Station, N.J., also recently applied to the Food and Drug Administration for approval to sell an immunotherapy tablet for ragweed pollen.

Subscribe today! Click here for our subscription offers.

 

 


Show commenting policy

Most-Read Business Headlines

  1. U.S. oil, natural gas rig count drops by 34 to 954
  2. Is Big Brother a backseat driver?
  3. Google’s changes to search results formula expected to shake up mobile economy
  4. Jump in home loans, trading commissions lead to profitable 1st quarter for banks
  5. Mylan discounts speculation of a possible takeover by Teva
  6. Pa. employers shed 12,700 jobs in March; unemployment rate rises to 5.3 percent
  7. Renewed fears of Greek default whack stock market
  8. Here’s how to clean your car
  9. Hearings set on new environmental rules for gas, oil drilling in Pa.
  10. PPG axes 1,700 jobs as part of global restructuring
  11. Review: Chevrolet Trax is an affordable SUV option